Try our Advanced Search for more refined results

FEDERAL TRADE COMMISSION v. ILLUMINA, INC. et al

Track this case

Case Number:

1:21-cv-00873

Court:

District Of Columbia

Nature of Suit:

Anti-Trust

Judge:

Rudolph Contreras

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 20, 2021

    FTC's Challenge To $8B Illumina Merger Shipped To Calif.

    Illumina's fight with the Federal Trade Commission over its $8 billion plan to buy cancer testing company Grail will take place in California federal court after a D.C. judge decided that a Golden State venue would be more convenient for witnesses.

  2. April 09, 2021

    FTC Says Moving Illumina Suit To Calif. Is Risky Amid COVID

    The Federal Trade Commission urged a D.C. federal judge not to move its challenge to Illumina's planned $8 billion merger with Grail Inc., planned as a remote hearing before the D.C. district court, to California where in-person hearings are permitted, saying the move would trigger "undeniable risk" from COVID-19.

  3. April 07, 2021

    Illumina Hits Back At FTC, Says $8B Grail Deal Can Save Lives

    Illumina Inc. urged a D.C. federal judge to jettison the Federal Trade Commission's challenge to its planned $8 billion acquisition of Grail Inc., saying the deal can save numerous lives through advances in early cancer detection.

  4. April 05, 2021

    Illumina Wants FTC's Suit Over $8B Grail Deal Moved To Calif.

    Illumina Inc. has urged a D.C. federal judge to send the Federal Trade Commission's suit challenging the biotech firm's planned $8 billion takeover of Grail Inc. to California, where the companies are based.

  5. April 01, 2021

    Illumina Agrees To Delay $8B Grail Deal During FTC Challenge

    Illumina Inc. has agreed to delay closing its planned $8 billion acquisition of cancer detection firm Grail Inc. until as late as September while the Federal Trade Commission challenges the deal in D.C. federal court.